Long-term continuation treatment after short-term day treatment of female patients with severe personality disorders: Body awareness group therapy versus psychodynamic group therapy

2010 ◽  
Vol 64 (2) ◽  
pp. 115-122 ◽  
Author(s):  
Harald Leirvåg ◽  
Geir Pedersen ◽  
Sigmund Karterud
Keyword(s):  
Group Therapy ◽  
Personality Disorders ◽  
Day Treatment ◽  
Body Awareness ◽  
Short Term ◽  
Female Patients ◽  
Psychodynamic Group Therapy ◽  
Continuation Treatment

Body Awareness Group Therapy for Patients with Personality Disorders

1989 ◽  
Vol 51 (1) ◽  
pp. 11-17 ◽  
Author(s):  
Ulla-Britt Skatteboe ◽  
Svein Friis ◽  
Magnhild Kvamsdal Hope ◽  
Per Vaglum
Keyword(s):  
Group Therapy ◽  
Personality Disorders ◽  
Body Awareness

scholarly journals Are short term savings worth long term costs? Funding treatment for personality disorders

1993 ◽  
Vol 17 (9) ◽  
pp. 517-519 ◽  
Author(s):  
D. Menzies ◽  
B. M. Dolan ◽  
K. Norton
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Personality Disorders ◽  
National Health ◽  
Quality Service ◽  
Short Term ◽  
New System

The new system of funding introduced by the National Health Service reforms has led to an increased awareness of financial concerns within the NHS. This was indeed one of the main aims of the reforms, with the expectation that a more efficient and better quality service would result. This may be a realistic aim, as long as clinicians' freedom to make appropriate secondary and tertiary referrals do not become totally dependent upon financial considerations. Yet it has become clear from findings within our own unit, Henderson Hospital, that, in at least 42% of cases, requests for ECR funding for treatment were refused on a purely financial basis (Dolan & Norton, 1992).

Concurrent Group and Family Treatment for Young Adults

1981 ◽  
Vol 62 (10) ◽  
pp. 614-621 ◽  
Author(s):  
Richard A. Dublin
Keyword(s):  
Young Adults ◽  
Group Therapy ◽  
Treatment Method ◽  
Family Treatment ◽  
Short Term ◽  
Intensive Group

A treatment method that is uniquely suitable for young adults combines the use of long-term, intensive group therapy with short-term family treatment. This approach addresses clients' defects, builds on their strengths, and, finally, reconnects them in an improved and more mature fashion with their families.

scholarly journals Multicentre Covariate Adjustment Analysis of Short-Term and 5-Year Outcomes after Endovascular Repair according to Sex

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Bibombe P. Mwipatayi ◽  
Rebekah L.W Tan ◽  
Joseph Faraj ◽  
Ali Daneshmand ◽  
Olufemi Oshin ◽  
...  
Keyword(s):  
Artery Bypass ◽  
Endovascular Aneurysm Repair ◽  
Adverse Event Rate ◽  
Short Term ◽  
Term Survival ◽  
Female Patients ◽  
Significant Difference ◽  
Male Patients ◽  
Composite Endpoints

Background. Several studies have reported worse outcomes in women compared to men after endovascular aneurysm repair (EVAR). This study aimed to evaluate sex-specific short-term and 5-year outcomes after EVAR. Methods. A total of 409 consecutive patients underwent elective EVAR from 2004 to 2017 at two tertiary hospitals in Western Australia. Baseline, intraoperative, and postoperative variables were examined retrospectively according to sex. The primary outcome was 30-day mortality (death within 30 days after EVAR). Secondary outcomes were 30-day composite endpoint, length of stay after EVAR, 5-year survival, freedom from reintervention, residual aneurysm size after EVAR, and major adverse event rate at 5-year follow-up. Results. A cohort of 409 patients, comprising 57 women (14%) and 352 men (86%), was analysed. Female patients were older (median age, 76.8 versus 73.5 years, p=0.017). Male patients were more likely to be past smokers (40.9% versus 22.8%, p=0.005) and have a history of coronary artery bypass grafting (11.2% versus 3.5%, p=0.042) and malignancy (24.1% versus 10.5%, p=0.014). No difference in 30-day mortality or composite endpoints was demonstrated for female patients compared with male patients (3.5% versus 0.3%, p=0.052 and 31.6% versus 27.8%, p=0.562, respectively). The Kaplan–Meier curves demonstrated similar 5-year mortality outcomes amongst male and female patients (p=0.928). Long-term survival analysis adjusting for covariates demonstrated no significant difference in long-term mortality, composite endpoints, and reintervention rate between sexes. Conclusion. This study found no significant differences in 30-day and 5-year outcomes between female and male patients treated with EVAR, implying that EVAR remains a safe treatment choice for female patients.

Sign in / Sign up

Export Citation Format

Share Document